⌘K

Home/Filings/4/0001127602-23-022197

4//SEC Filing

ABERNATHY ROBERT E 4

Accession 0001127602-23-022197

CIK 0000313143other

View on SEC.gov Company Profile

Filed

Aug 7, 8:00 PM ET

Accepted

Aug 8, 4:27 PM ET

Size

4.6 KB

Accession

0001127602-23-022197

Insider Transaction Report

Form 4

Period: 2023-08-04

HAEMONETICS CORPHAE

ABERNATHY ROBERT E

Director

Transactions

Award
Common Stock
2023-08-04+2,226→ 20,081 total

Footnotes (2)

[F1]The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.
[F2]Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

HAEMONETICS CORP

CIK 0000313143

Entity typeother

Related Parties

1

filerCIK 0001222888

Filing Metadata

Form type: 4
Filed: Aug 7, 8:00 PM ET
Accepted: Aug 8, 4:27 PM ET
Size: 4.6 KB

View on SEC.gov